Tag Archives: IPF

Change in airway volume, measured with FRI, differentiates between stable and progressive IPF.

This study will be presented at ERS 2019 at a thematic poster session on Sunday September 29 between 12.50 pm and 2.40 pm.

In a retrospective imaging analysis study, FRI ( Functional Respiratory Imaging )compared CT scans of IPF (Ideopathic Pulmonary Fibrosis) patients from two cohorts. 12 treatment-naïve IPF patients were sequentially identified at a tertiary IPF center as stable (absolute FVC decline <10%) or progressive (≥10%) between 2 CT time points.

 

Results showed significant (p<0.05) differences between the two cohorts in specific airway volume (siVaw) in both central and distal airways. Total siVaw increased by 30% in the progressive vs. an 11% decrease in stable group (p=0.0002). Regression found several correlations with FVC change including Total siVaw (R2 0.39).

Airway volume may be an important parameter in IPF progression and shows interesting correlations with FVC. This parameter could monitor disease course for patients and act as endpoints for future IPF clinical trials.

Jan de Backer, CEO and founder of Fluidda, speaks about the partnership with Materialise at the ATS conference.

De Backer states: “We are very excited and proud to enter into this new phase of partnership with Materialise. We share the vision that the medical field, and particularly respiratory healthcare imaging needs to evolve towards personalized, precision medicine through a value-based healthcare approach. We are confident that advanced imaging techniques, such as our Functional… Continue Reading

CEO FLUIDDA appointed to Board of Directors of OSIC (Open Source Imaging Consortium)

Jan de Backer, CEO and founder of FLUIDDA, has been appointed to the Board of Directors of the new global non-profit organization OSIC (Open Source Imaging Consortium). The OSIC is a cooperative effort between academia, industry and philanthropy to enable rapid advances in the fight against Idiopathic Pulmonary Fibrosis (IPF) and other progressive interstitial lung… Continue Reading

ATS Conference 2018 | 18-23 May | San Diego, CA

Not only will FLUIDDA present at the first Respiratory Innovation Summit at the American Thoracic Society conference 2018, we also have a strong scientific program with 7 Functional Respiratory Imaging  related presentations. Looking forward to seeing you at booth 2542!   Sunday, May 20     Monday, May 21             Tuesday, May… Continue Reading

FLUIDDA’s IPF Catalyst Challenge Entry

FLUIDDA is excited to join the IPF Catalyst Challenge! Functional Respiratory Imaging (FRI) is a very promising tool for early diagnosis, disease staging and progression and as a sensitive biomarker in drug development trials. As part of the challenge we would like to build a framework to enhance patient care through FRI because we believe… Continue Reading

Introduction to Functional Respiratory Imaging (FRI) for Investors and Market Analysts

For those who cannot attend our event coming Thursday at Flanders House in New York, you are welcome to register for the Webcast via following link: https://attendee.gotowebinar.com/register/8186175617140384514       FLUIDDA is delighted to invite you to a dedicated session discussing her proprietary Functional Respiratory Imaging (FRI) technology and its application in drug and device… Continue Reading

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

All content © FLUIDDA 2019